Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.44 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | HMGCR | P04035 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862477 | 0.88 | KMT2A (0.47) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL27915406 | 0.87 | DDR1 (0.46) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL28786236 | 0.84 | F2R (0.45) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL14236191 | 0.84 | KMT2A (0.44) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL5838889 | 0.83 | KDM4E (0.50) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL16151849 | 0.82 | RXRA (0.48) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL14240790 | 0.81 | SMN1; SMN2 (0.57) | KMT2APOLBKDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL333513 | 0.81 | GSK3B (0.66) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL10497616 | 0.81 | KDM4E (0.49) | KMT2APOLBKDM4EGAASMN1; SMN2 | |
| SCHEMBL1038708 | 0.80 | HSD17B3 (0.50) | KDM4EGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114751576-A | Method for treating dialkoxybenzene production wastewater | 北京惠宇乐邦环保科技有限公司 | 2022-07-15 | — | — | CN | claimed |
| EP-4709724-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | Jazz Pharmaceuticals Research UK Limited (GB) | 2026-03-18 | — | — | EP | disclosed |
| EP-3722276-B1 | PROCESS FOR THE PRODUCTION OF PURIFIED CANNABIDIOL | PURISYS LLC (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2024236275-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2024-11-21 | — | — | WO | disclosed |
| US-11912736-B2 | Diaryl trehalose compounds and uses thereof | THE UNIVERSITY OF MONTANA (US) | 2024-02-27 | — | — | US | disclosed |
| CN-110526854-B | Alpha, beta-unsaturated ketone derivative, preparation method and application thereof as medicine | 宁夏医科大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-114751576-A | Method for treating dialkoxybenzene production wastewater | 北京惠宇乐邦环保科技有限公司 | 2022-07-15 | — | — | CN | disclosed |
| US-20210139521-A1 | DIARYL TREHALOSE COMPOUNDS AND USES THEREOF | THE UNIV OF MONTANA (US) | 2021-05-13 | — | — | US | disclosed |
| US-20210061781-A1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | NORAMCO, INC. | 2021-03-04 | — | — | US | disclosed |
| US-20210061781-A1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | NORAMCO, INC. | 2021-03-04 | — | — | US | disclosed |
| US-4400385-A | TRANQUILIZERS, HYPOTENSIVE AGENTS; DIURETICS; VISION DEFECTS | PFIZER INC. (US) | 1983-08-23 | — | — | US | disclosed |
| US-4380542-A | ANALGESICS, TRANQUILIZERS | PFIZER (US) | 1983-04-19 | — | — | US | disclosed |
| US-4340737-A | CNS AGENTS, HYPOTENSIVES, DIURETICS AND AGENTS FOR TREATMENT OF GLAUCOMA | PFIZER INC. (US) | 1982-07-20 | — | — | US | disclosed |
| US-4260764-A | ANALGESICS, TRANQUILIZERS | PFIZER INC. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4243674-A | HYPOTENSIVE AGENTS; ANALGESICS; ANTISECRETORY AGENTS; ANTIBODY INHIBITORS, AND TRANQUILIZERS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| US-4143139-A | ANALGESICS, HYPOTENSIVES, IMMUNOSUPPRESSANTS, TRANQUILIZERS, ANTISECRETORY, ANTI-ANXIETY | PFIZER INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-RE29196-E | ANALGESICS AND TRANQUILIZERS | ABBOTT LABORATORIES (US) | 1977-04-26 | — | — | US | disclosed |
| US-3947462-A | 2,4,7-substituted 5-hydroxy benzopyrans and esters | ABBOTT LABORATORIES (US) | 1976-03-30 | — | — | US | disclosed |
| US-3932432-A | Alkylphenyl benzopyranopyridines | ABBOTT LABORATORIES (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931232-A | 3-Alkyl xanthene compounds | SMITHKLINE CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061781-A1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | CNR2, HDHD5, DAGLA | KMT2A 3227/4885POLB 988/4885KDM4E 2928/4885 |
| US-20210139521-A1 | DIARYL TREHALOSE COMPOUNDS AND USES THEREOF | TREH, STT3B, DDOST | KMT2A 4228/4885POLB 3142/4885KDM4E 4381/4885 |
| US-11912736-B2 | Diaryl trehalose compounds and uses thereof | TREH, STT3B, DDOST | KMT2A 4228/4885POLB 3142/4885KDM4E 4381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.